EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Immunometabolic Targets in CD8 + T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma

Yanze Lin, Rexiati Ruze, Ruiqing Zhang, Talaiti Tuergan, Maolin Wang, Alimu Tulahong, Dalong Zhu, Zhongdian Yuan, Tiemin Jiang, Tuerganaili Aji, Yingmei Shao

Liver Cancer · 2024-11-21 · 14 (4) · 474-496

DOI: 10.1159/000542578 ↗
AbstractBibliografische Angaben

Abstract

Background: CD8+ T cells are critical for the oncogenesis and progression of the hepatocellular carcinoma (HCC) tumor microenvironment, receiving antigen signals from antigen-presenting cells and directly contributing to antitumor responses. Summary: CD8+ T cells mediate immunogenic cell death, facilitate immune signal transmission, and play a significant role in various treatments, including surgery, transarterial chemoembolization, and immunotherapy. Extensive research on the role of CD8+ T cells within the HCC microenvironment has shown considerable progress. Immunometabolic targets on CD8+ T cells have demonstrated potential in combination with immunotherapies for HCC; however, they have not yet reached the clinical trial stage. Key Messages: This review provides a comprehensive overview of recent research on immune and immunometabolic targets of CD8+ T cells within the HCC microenvironment. By highlighting advances and potential mechanisms, this review aims to support the development of effective clinical strategies in this field.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →